When a five-year-old boy suffered severe burns covering 91% of his body, doctors faced a mysterious challenge: cytokine storms. These storms, though recognized in various conditions, are not frequently discussed in burn cases. The boy experienced three cytokine storms during his hospital stay. Docto
For over ten years, scientists have been testing a special combination of medications called the polypill. This pill is designed to tackle atherosclerotic cardiovascular disease (ASCVD), which is a fancy name for heart diseases caused by clogged arteries. Now, researchers are wondering if this same
Ever thought about the tiny critters in soil that help plants grow? We're talking about microbes, and they love nitrogen (N)! Scientists have a nifty tool called qSIP to see which microbes are using N. Usually, this is done in a lab. But what about in the real world? Two sites were picked to compare
Hindenburg Research, known for its short-seller tactics targeting tech and EV companies, is closing down. Nate Anderson, the founder, announced this news in a blog post, citing personal reasons and the toll the work took on his health and life. Hindenburg Research gained fame for its investigative r
Rwanda has become a key player in the global battle against rheumatic heart disease (RHD). The country is home to the Rwanda RHD Research Network, which serves as a central hub for international collaboration. This network brings together scientists, doctors, and public health experts from around th
Picture this: scientists trying to follow tiny dancers on a bustling stage. In this case, the dancers are CB2 receptors, and the stage is the surface of living cells. To make these receptors visible, researchers used a special light-up tag called RO7304924. This tag attaches only to CB2 receptors, m
Hey there! Did you know that certain groups of people, who speak different languages or come from different cultures, often miss out on research about heart diseases? That’s not fair, right? Let's dive in and find out why this happens and what we can do to change it. First off, even though these di
François Chollet, a well-known figure in the AI world, is starting a new venture called Ndea. This isn't just any startup; it's a research lab with a big goal: to create Artificial General Intelligence (AGI). AGI is like having AI that can do anything a human can. It's a dream for many AI companies,
When it comes to science, Democrats and Republicans often clash. But one thing they do agree on is the uncertainty about animal testing. Some love it, some hate it. President Trump's reign might cut funding for such research, which could be great for animals. But will it really help science? Let's l
Neurodegenerative diseases are like intricate puzzles that scientists are working hard to solve. They affect both small components (like molecules and cells) and large aspects (such as physiology) of the brain. Traditional tools aren't doing the job well, but a new technology called microfluidics mi
